1 Min Read
Nov 9 (Reuters) - HERANTIS PHARMA OYJ:
* SHARES MAY BE ISSUED, AMONG OTHERS, FOR PURPOSES OF FINANCING LYMFACTIN CLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.